Literature DB >> 15845271

Cellular uptake of the EBV transcription factor EB1/Zta.

Ségolène Mahot1, Pascal Fender, Romain R Vivès, Cécile Caron, Monique Perrissin, Henri Gruffat, Alain Sergeant, Emmanuel Drouet.   

Abstract

A number of viral proteins have the property to penetrate into the cells when present in the extra-cellular compartment. Here, we report that the Epstein-Barr virus (EBV) transcriptional activator EB1/Zta, which is responsible for the activation of the EBV lytic replication, binds to lymphoid cells surface, is efficiently translocated and accumulates in the nucleus. The internalization of EB1/Zta is energy-dependent and shares common features with endocytosis. As the EB1/Zta was not degraded in the cells and reached the nucleus, the potential effect of its internalisation on viral reactivation was assessed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845271     DOI: 10.1016/j.virusres.2005.01.014

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.

Authors:  Romy Rothe; Lavinia Liguori; Ana Villegas-Mendez; Bruno Marques; Didier Grunwald; Emmanuel Drouet; Jean-Luc Lenormand
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

Review 2.  The physiological basis of intracrine stem cell regulation.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

3.  Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.

Authors:  Mohammed Habib; Marlyse Buisson; Julien Lupo; Felix Agbalika; Gérard Socié; Raphaele Germi; Monique Baccard; Berthe-Marie Imbert-Marcille; Jacques Dantal; Patrice Morand; Emmanuel Drouet
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

4.  Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy.

Authors:  Ivona Nečasová; Martin Stojaspal; Edita Motyčáková; Tomáš Brom; Tomáš Janovič; Ctirad Hofr
Journal:  NAR Cancer       Date:  2022-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.